53
Participants
Start Date
December 31, 2004
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2008
monoclonal antibody RAV12
Escalating doses of RAV12 (weekly 0.3, 1.0, 1.5, 3.0, 4.0, 5.0, 6.0 mg/kg or 0.5 mg/kg BIW or TIW; 0.75 mg/kg BIW) for 4 weeks
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington D.C.
University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami
Sarah Cannon Cancer Center at Centennial Medical Center, Nashville
Premiere Oncology, Santa Monica
Fox Chase Cancer Center - Philadelphia, Philadelphia
Lead Sponsor
MacroGenics
INDUSTRY